ZIOPHARM Oncology Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
142.38 M |
Public Float |
130.44 M |
ZIOPHARM Oncology Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.42 |
Market Cap |
$954.88 M |
Shares Outstanding |
162.39 M |
Public Float |
153.95 M |
Address |
Parris Building Boston Massachusetts 02129 United States |
Employees | - |
Website | http://www.ziopharm.com |
Updated | 07/08/2019 |
ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of a diverse portfolio of cancer therapies. It focuses on developing products in immuno-oncology that employ novel gene expression, control, and cell technologies for the treatment of cancer. The company was founded on September 9, 2003 and is headquartered in Boston, MA. |